Your child
deserves to thrive
Medically supervised GLP-1 management for adolescents ages 12 to 17, with a personalized nutrition plan and coaching, and behavioral support. FDA-approved medications only.
Currently serving families in AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, TX & VA. Expanding throughout 2027.
GLP-1 therapy works
unsupervised, it carries real risks
GLP-1s without oversight put growing kids at risk. A prescription without a plan is not a treatment. We prescribe, we manage, and we stay with your child every step of the way.
- Behavioral coaching builds habits that outlast the prescription
- Structured nutrition plans protect lean muscle and support healthy growth
- Patients learn to maintain results after stopping medication
- Proactive GI monitoring and dose management keep side effects from forcing early discontinuation
- Monthly check-ins and lab reviews catch every risk before it becomes a problem
One plan. Everything
your child needs
Is this my child?
Thryvwell works with adolescents ages 12 to 17. If any of the following sounds familiar, your child may qualify.
Has your child's pediatrician mentioned their weight at recent visits?
A BMI at or above the 95th percentile for age and sex is the primary eligibility threshold. Adolescents with a BMI at or above the 85th percentile may qualify if they have a weight-related condition.
Has your child been told they have prediabetes, high blood pressure, or high cholesterol?
Weight-related health conditions make a child a strong candidate for early intervention.
Has your child tried to lose weight before without lasting results?
Behavioral and nutritional support alongside medication addresses the habits, not just the number on the scale.
Is your child between 12 and 17 years old?
Thryvwell is designed specifically for adolescents. Patients who turn 18 during the program receive a warm handoff to an adult provider.
Clinical criteria
for eligibility
Thryvwell evaluates each patient individually. The conditions below represent the primary clinical indications for GLP-1 therapy in adolescents.
- ObesityBMI at or above the 95th percentile for age and sex
- Overweight with a comorbidityBMI 85th to 94th percentile with a weight-related condition
- PrediabetesElevated fasting glucose or HbA1c
- Metabolic syndromeCluster of weight-related metabolic risk factors
- Non-alcoholic fatty liver diseaseWeight-related liver inflammation
- DyslipidemiaAbnormal cholesterol or triglycerides related to weight
Final eligibility is always confirmed by a Thryvwell clinician at the intake visit. This list is not exhaustive. If you are unsure whether your child qualifies, we encourage you to reach out.
The support
your child's GLP-1 requires
GLP-1 prescriptions for adolescents have risen nearly 600% since 2020.¹ The wraparound support those prescriptions require has not kept pace. Thryvwell closes that gap.
¹ Lee JM et al. Dispensing of GLP-1 receptor agonists to adolescents and young adults, 2020–2023. JAMA, 2024.